GJO & Partners
← All funds

Amethis

Public data, unclaimed profile

Fund manager dedicated to Africa and the Middle East, part of the Edmond de Rothschild group.

At a glance

Based on observed investment behaviour: 8 recorded deals

Investor type
Private equity or venture capital fund (inferred, not verified)
Capital type
Private equity (inferred from deals)
Observed ticket
Data unavailable
Stated ticket : 10 M$ – 40 M$
Countries
Côte d'Ivoire (2), South Africa (2), Kenya (1)
Activities
Clinics and hospitals (1), Commercial & industrial energy (1), Food processing (1)
Instruments
Equity (6), Quasi-equity (1)
Stages
Growth (8)
Recent activity
3 deals in 12 months, latest Sept 2026

Stated thesis versus observed behaviour

  • Sectors: 75% of its deals within its stated thesis
  • Countries: 71% of its deals within its stated thesis

Does this fund fit your project?

Describe your need: the target list shows, for each source of capital, why it fits and which deals prove it.

Find my matches

Investment thesis

Criteria published by the fund, recorded and checked by Invest Matching.

Investment ticket
10 M$ – 40 M$
Instruments
Equity
Preferred sectors
Financial services, Retail & distribution, Healthcare, Agribusiness, Manufacturing, Energy*, Telecoms & digital infrastructure*
Target geographies
West Africa, East Africa, North Africa, Côte d'Ivoire, Kenya, Morocco, South Africa*

* added from its deals

Stages (stated by the fund and from its deals)
Growth

Team and contacts

LinkedIn profiles, emails and phone numbers are reserved for signed-in members: create an account to access them.

Reference deals

Recent public deals: they say better than a thesis what the fund actually signs.

Zamara Holdings

September 2026 · Kenya
GrowthUndisclosed amountEquityFinancial servicesLead

Activity : Insurance

Instrument : Growth capital

Group founded in 1994 in Nairobi: insurance broking, pension administration and actuarial services in Kenya, Uganda, Tanzania, Rwanda, Nigeria, Malawi, DRC and the UAE; 3,700+ insurance clients.

Why they invested

  • Accelerate digital capabilities
  • Consolidate regional leadership and broaden the offer
  • Organisational transformation and strategic partnerships

Team

  • Sundeep Raichura — Group CEO

Source : amethis.comN1 · Primary source

Vertice MedTech

April 2026 · South Africa
GrowthUndisclosed amountEquityHealthcareCo-Lead

Activity : Medical devices and equipment

Instrument : Consortium buyout with management (seller: Ethos Private Equity)

Southern Africa's leading independent distributor of specialised medical devices and a healthcare software provider: 780 staff, 3 distribution centres, 7,000+ surgical procedures a month, exclusive agreements with 100+ manufacturers (Abbott, Stryker…). Acquired from Ethos Private Equity by Amethis, Proparco, ccap.ai and management.

Why they invested

  • Independent leader with exclusive agreements with major manufacturers
  • Data- and software-driven healthcare platform
  • Management co-investing

Advisers

  • Investec — financement, buyer side
  • Bowmans — juridique (Amethis), buyer side
  • DLA Piper — juridique (Proparco), buyer side
  • Husemeyer Advisors — juridique (ccap.ai), buyer side
  • FTI — due diligence financière, buyer side
  • Cadena — due diligence commerciale, buyer side
  • SLR — ESG et impact, buyer side
  • Nedbank CIB — transaction, seller side
  • Webber Wentzel — juridique, seller side
  • EY — financier, seller side

Team

  • Hendri Pretorius — CEO
  • Jonathan Lowick — CFO

Co-investors ccap.ai, Proparco (Co-Lead)

Source : amethis.comN1 · Primary source

ADEMAT

March 2026 · Côte d'Ivoire
GrowthUndisclosed amountEnergyLead

Activity : Commercial & industrial energy

Instrument : Amount and stake undisclosed · Vehicle : Small & Mid Caps Afrique

Energy security solutions: distribution of generators, voltage regulation and transformation equipment (partners Kohler | SDMO, Leroy-Somer), installation, maintenance and rental; 100+ staff.

Why they invested

  • Develop solar photovoltaics
  • Accelerate ADEMAT's own brand
  • Regional expansion in West and Central Africa through acquisitions and partnerships
  • Ambitious ESG strategy, lower-carbon solutions

Source : amethis.comN1 · Primary source

Netis

November 2023
GrowthUndisclosed amountEquityTelecoms & digital infrastructureCo-Invest

Activity : Telecom towers and fibre

Instrument : Prise de participation majoritaire

Netis provides telecom site maintenance, fiber-optic deployment and power-supply solutions across more than 15 countries in Sub-Saharan Africa.

Why they invested

  • Capture the fast-growing African telecom installation and maintenance market
  • Accelerate digital inclusion across Africa
  • Support Netis' expansion into new countries
  • Support the development of telecom and energy infrastructure

Co-investors AfricInvest, IFC (International Finance Corporation), Proparco

Source : amethis.comN1 · Primary source

Avacare Global

September 2021 · South Africa
GrowthUndisclosed amountEquityHealthcareCo-Invest

Activity : Pharmacy and drug distribution

Instrument : Prise de participation minoritaire

Avacare is a pan-African pharmaceutical distributor and manufacturer operating mainly in Southern Africa, with operations also in Kenya and several other African countries.

Why they invested

  • Improve access to affordable and innovative treatments in Africa
  • Support the group's expansion of manufacturing activities
  • Benefit from the growth of the African healthcare market
  • Support the strengthening of local pharmaceutical production capacity

Source : amethis.comN1 · Primary source

Nouvelle Minoterie Africaine (NMA)

February 2021 · Senegal
GrowthUndisclosed amountEquityAgribusinessLead

Activity : Food processing

Instrument : Prise de participation minoritaire

NMA manufactures and distributes livestock and poultry feed, wheat flour and pasta, and also conducts trading activities.

Why they invested

  • Build on strong brand equity
  • Support a company holding significant market shares across several product categories
  • Support the company's next stage of development
  • Partner with an established Senegalese industrial player

Source : amethis.comN1 · Primary source

Groupe HMAO (Holding Médicale d'Afrique de l'Ouest)

November 2015 · Côte d'Ivoire
GrowthUndisclosed amountEquityHealthcareLead

Activity : Clinics and hospitals

Instrument : Minority stake by Amethis, with Amethis West Africa; amount not disclosed

Ivorian private healthcare group: six clinics, a dental clinic and a medical laboratory.

Source : amethis.comN1 · Primary source

Boulos Group / Elephant Africa Holding

August 2015 · Nigeria
GrowthUndisclosed amountQuasi-equityManufacturingCo-Invest

Activity : Paper, board and printing

Instrument : Prêt convertible avec conversion en participation minoritaire · Vehicle : Amethis Finance

Elephant Africa Holding controls Bel Papyrus and Bel Impex, Nigerian producers of tissue paper, jumbo reels and hygiene products using recycled waste paper.

Why they invested

  • Support the modernization of a family-owned business
  • Support regional expansion in West Africa
  • Leverage the company's industrial and commercial position in Nigeria
  • Develop a local consumer-goods champion

Advisers

  • Kyte Partners — Conseil financier, seller side

Co-investors EuroMena Fund III

Source : amethis.comN1 · Primary source

Known limited partners

Investors that subscribed to this fund, according to their announcements.

In short

Amethis invests tickets ranging from 10 M$ to 40 M$, across the following sectors: Financial services, Retail & distribution, Healthcare, Agribusiness, Manufacturing, Energy, and Telecoms & digital infrastructure, in the following areas: West Africa, East Africa, North Africa, Côte d'Ivoire, Kenya, Morocco, and South Africa. Check in 30 seconds whether your company fits these criteria.